JAMUNARANI VEERARAGHAVAN to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications JAMUNARANI VEERARAGHAVAN has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.035
-
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade. J Natl Cancer Inst. 2020 01 01; 112(1):46-54.
Score: 0.019
-
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer. Clin Cancer Res. 2017 Sep 01; 23(17):5123-5134.
Score: 0.016